HS Pipeline Watch: First Patient Dosed in Phase 2 Trial of AVTX-009; Topline Data Expected in 2026

October 8, 2024

EADV News: Bimekizumab Shows Long-term Efficacy and Safety in HS

September 27, 2024

Breaking News From EADV: Semaglutide Reduces Flares and Improves Quality of Life for Obese Patients With HS

September 24, 2024

The Patient’s Perspective: Diagnosing and Treating HS

August 29, 2024

Talking About Mental Health With HS Patients

August 26, 2024

Ushering in a New Era for HS Patients

August 26, 2024

MoonLake Immunotherapeutics Receives Regulatory Greenlights for Phase 3 Program of Sonelokimab in PsA

June 10, 2024

AARS Offers Social Toolkit to Help Spread #AcneFacts During National Acne Awareness Month

May 28, 2024

News You Can Use: First Global HS Atlas Now Available From GHiSA, ILDS

May 28, 2024

Phase 3 Data: Bimekizumab Earns High Marks in HS

May 23, 2024

HS Pipeline Watch: MoonLake Immunotherapeutics’ Sonelokimab Advances to Phase 3

May 16, 2024

Adalimumab Improves Hematologic Abnormalities in HS Patients

May 9, 2024